Oral tofacitinib, baricitinib and upadacitinib monotherapy for steroid‐resistant vitiligo: A prospective case series

The authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.